FOR PATIENTS · SOURCE READING
Targeted therapy
Source: Childhood Acute Lymphoblastic Leukemia (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 15, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Context: Types of treatment for childhood acute lymphoblastic leukemia
Targeted therapy uses drugs or other substances to block the action of specific enzymes, proteins, or other molecules involved in the growth and spread of cancer cells. Often, targeted therapies are only used in specific ALL subtypes in which the specific target of the drug is present. Targeted therapy used or studied to treat childhood ALL includes:
bortezomib
Source links and citations
dasatinib
Source links and citations
imatinib mesylate
Source links and citations
inotuzumab ozogamicin
Source links and citations
nivolumab
Source links and citations
ruxolitinib
Source links and citations
Learn more about Targeted Therapy to Treat Cancer.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle